Research programme: inhaled tuberculosis vaccine - Profile Therapeutics/University of Oxford
Alternative Names: Inhaled tuberculosis vaccine research programme - Profile Therapeutics/University of OxfordLatest Information Update: 18 Aug 2003
At a glance
- Originator Profile Therapeutics; University of Oxford
- Class
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Tuberculosis
Most Recent Events
- 18 Aug 2003 Discontinued - Preclinical for Tuberculosis in United Kingdom (Inhalation)
- 21 Mar 2002 Preclinical trials in Tuberculosis in United Kingdom (Inhalation)